During the past decade, Wenzhou Central Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wenzhou Central Hospital" #1 sponsor was "Fudan University" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "ShuGuang Hospital" with 2 trials sponsored, "Beijing Tiantan Hospital" with 1 trials sponsored and "Daiichi Sankyo, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wenzhou Central Hospital" #1 collaborator was "Shandong University of Traditional Chinese Medicine" with 3 trials as a collaborator, "Shenzhen Third People's Hospital" with 3 trials as a collaborator, "Wenzhou Central Hospital" with 3 trials as a collaborator, "Beijing Ditan Hospital" with 2 trials as a collaborator and "Beijing YouAn Hospital" with 2 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 110 trials.

According to Clinical.Site data, the most researched conditions in "Wenzhou Central Hospital" are "Acute Ischemic Stroke" (1 trials), "Acute Pyelonephritis" (1 trials), "Adverse Drug Reaction" (1 trials), "Bacteremia" (1 trials) and "Drug Allergy" (1 trials). Many other conditions were trialed in "Wenzhou Central Hospital" in a lesser frequency.

Most popular intervention types in "Wenzhou Central Hospital" are "Drug" (8 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Zavicefta, Ceftazidime-Avibactam" (2 trials), "Best Available Treatment" (1 trials), "Edoxaban" (1 trials), "Entecavir + Fuzheng Huayu Tablet" (1 trials) and "Entecavir + Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wenzhou Central Hospital" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Wenzhou Central Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Wenzhou Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wenzhou Central Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".